
OpGen Investor Relations Material
Latest events

Q2 2023
OpGen
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from OpGen Inc
Access all reports
OpGen, Inc. is a precision medicine company that focuses on developing molecular diagnostic tools for the detection of infectious diseases. The company's products and services include rapid diagnostic tests and bioinformatics solutions designed to identify bacterial pathogens and antibiotic resistance. OpGen serves healthcare providers and laboratories, aiming to improve patient outcomes through faster, more accurate diagnostics for conditions such as urinary tract infections and bloodstream infections. The company is headquartered in Rockville, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
OPGN
Country
🇺🇸 United States